Mr. Marcus Keane:

We identify a couple of countries in the report. In the European context, Scotland has been very effective and is reportedly on target to have met the World Health Organization's guidelines by 2024, which is a number of years ahead of target. As for the way Scotland has done that, there are policy documents published about it. It has looked to increase community access, to make things as accessible as possible for people, to set micro-elimination targets so to be able to encourage clinicians and healthcare professionals to work towards these clearly identifiable numerical targets, having those targets published and visible. Scotland is therefore a good example to consider in the European context. Egypt has also done a huge amount of work on hepatitis C elimination. There are examples of good practice out there that we can draw on. The recommendations we make speak to that and look to driving towards that.